The calm and focused approach of Andrew Dillon has proved invaluable in weathering the storms faced by the National Institute for Health and Clinical Excellence.

As chair Sir Mike Rawlins’ right hand man, Mr Dillon has worked tirelessly to protect the reputation of the institute despite a very challenging year which included negative media coverage of its decisions on drug recommendations.

NICE’s new role in overseeing GP quality and outcomes framework targets was also met with opposition, from the British Medical Association GPs committee.However, Mr Dillon managed to win the committee over to a significant shift in their stance.